Wellmaxx phase² solution concentrate REFINE 7x1ml

Wellmaxx phase² solution concentrate REFINE 7x1ml


Ended sale. More

Manufacturer: Wellmaxx Product code: 1012/4 Shipping and Payment

30 €
In stock

Ended sale. More

Manufacturer: Wellmaxx Product code: 1012/4 Shipping and Payment

Description and usage

REFINE Concentrate contains a high-dosage hyaluronic acid combination and carefully selected active ingredients such as XEP™-018, carnosine and niacin. These systems of active ingredients can firm1 the skin and stimulate cell activation. The complexion appears fresher, fuller and more youthful. The hyaluronic acid also provides an extra helping of freshness and vitality2.

1XEP™-018: Clinical studies prove a reduction in wrinkles and fine lines. A study with 24 test subjects (average age 30-40 years) shows a significant reduction 2 hours after application. Another study with 33 test subjects shows significant improvements in wrinkles around the eyes and forehead wrinkles, 8 hours after application. Test subjects reported improvements of up to 93% in the way the skin feels, and 79% reduction in wrinkles around the eyes.

2Hyaluronic acid complex: Study of active ingredients, 10 test subjects, average age 40 years, female, 4 weeks, applied twice daily. Skin elasticity increased by 21.6%, and wrinkle depth and skin roughness decreased by 24.4%. Oligomeric hyaluronic acid and small-molecular hyaluronic acid have excellent penetration properties and boost the levels of moisture in the skin.

Ingredients: 

Aqua (Water), Prunus Amygdalus Dulcis (Sweet Almond) Oil, Caprylic/Capric Triglyceride, Sodium Hyaluronate, Sodium Hyaluronate (Crosslinked), Glycerin, Mu-conotoxin CnIIIC, Carnosine, Niacin, Phenoxyethanol, Benzoic Acid, Dehydroacetic Acid, Parfume,CI 60725.

Please note that the mentioned ingredients correspond to the current status of production. The ingredients on the respective cosmetics packaging are relevant as we continuously check these and at the same time incorporate the new and innovative scientific results.